A phase III randomized study comparing neoadjuvant chemotherapy with concurrent chemotherapy combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma: Updated long-term survival outcomes

Oral Oncology

Volumn 50, Issue 2, 2014, Pages 71-76

  Xu, Tingting ^a   Zhu, Guopei ^a   He, Xiayun ^a   Ying, Hongmei ^a   Hu, Chaosu ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Chemoradiotherapy; Concurrent chemotherapy; Nasopharyngeal carcinoma; Neoadjuvant chemotherapy; Randomized study

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CHEMOTHERAPY INDUCED EMESIS; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NASAL BIOPSY; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PATIENT ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; VOMITING;

CHEMORADIOTHERAPY; CONCURRENT CHEMOTHERAPY; NASOPHARYNGEAL CARCINOMA; NEOADJUVANT CHEMOTHERAPY; RANDOMIZED STUDY;

ADOLESCENT; ADULT; AGED; CHEMORADIOTHERAPY; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOADJUVANT THERAPY; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84891826853     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.11.002     Document Type: Article

References (27)

1. A. Jemal, F. Bray, and M.M. Center et al. Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. F.B. Geara, G. Sanguineti, and S.L. Tucker et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival Radiother Oncol 43 1997 53 61
3. D.G. Pfister, K.K. Ang, and D.M. Brizel et al. Head and Neck Cancers, Version 2.2013 J Natl Compr Cancer Netw 11 2013 917 923
4. A.W. Lee, W.H. Lau, and S.Y. Tung et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 trial by the Hong Kong nasopharyngeal cancer study group J Clin Oncol 23 2005 6966 6975
5. J.C. Lin, W.M. Liang, and J.S. Jan et al. Another way to estimate out-come of advanced nasopharyngeal carcinoma - is concurrent chemoradiotherapy adequate? Int J Radiat Oncol Biol Phys 60 2004 156 164
6. D.T. Chua, J. Ma, and J.S. Sham et al. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials J Clin Oncol 23 2005 1118 1124
7. J.A. Langendijk, C.R. Leemans, and J. Buter et al. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature J Clin Oncol 22 2004 4604 4612
8. B. Baujat, H. Audry, and J. Bourhis et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients Int J Radiat Oncol Biol Phys 64 2006 47 56
9. M. Al-Sarraf, M. LeBlanc, and P.G. Shanker et al. Chemotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099 J Clin Oncol 16 1998 1310 1317
10. G. Fountzilas, E. Ciuleanu, and M. Bobos et al. Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation Ann Oncol 23 2012 427 435
11. L. Chen, C.S. Hu, and X.Z. Chen et al. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial Lancet Oncol 13 2012 163 171
12. T. Xu, C. Hu, and G. Zhu et al. Preliminary results of a phase III randomized study comparing chemotherapy neoadjuvantly or concurrently with radiotherapy for locoregionally advanced nasopharyngeal carcinoma Med Oncol 29 2012 272 278
13. J. Ma, H.Q. Mai, and M.H. Hong et al. Results: of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma J Clin Oncol 19 2001 1350 1357
14. J.C. Lin, J.S. Jan, and C.Y. Hsu et al. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival J Clin Oncol 21 2003 631 637
15. Y. Chen, Y. Sun, and S.B. Liang et al. Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone inpatients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China Cancer 119 2013 2230 2238
16. S.Z. Lai, W.F. Li, and L. Chen et al. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys 80 2011 661 668
17. P.Y. Ouyang, C. Xie, and Y.P. Mao et al. Significant efficacies of neoadjuvant and adjuvant chemotherapy for nasopharyngeal carcinoma by meta-analysis of published literature-based randomized, controlled trails Ann Oncol 24 2013 2136 2146
18. Z.G. Liang, X.D. Zhu, and A.H. Tan et al. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy with or without adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: meta-analysis of 1,096 patients from 11 randomized controlled trials Asian Pac J Cancer Prev 14 2013 515 521
19. E.P. Hui, B.B. Ma, and S.F. Leung et al. Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma J Clin Oncol 27 2009 242 249
20. L. Kong, Y.W. Zhang, and C.S. Hu et al. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma Chin J Cancer 29 2010 551 555
21. W.K. Bae, J.E. Hwang, and H.J. Shim et al. Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer Cancer Chemother Pharmacol 65 2010 589 595
22. M.R. Posner, D.M. Hershock, and C.R. Blajman et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 2007 1705 1715
23. J.B. Vermorken, E. Remenar, and C. van Herpen et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 357 2007 1695 1704
24. Y. Pointreau, P. Garaud, and S. Chapet et al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation J Natl Cancer Inst 101 2009 498 506
25. R. Hitt, A. López-Pousa, and J. Martínez-Trufero et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer J Clin Oncol 23 2005 8636 8645
26. J.H. Lorch, O. Goloubeva, and R.I. Haddad et al. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial Lancet Oncol 12 2011 153 159
27. A. Argiris, and M.V. Karamouzis Empowering induction therapy for locally advanced head and neck cancer Ann Oncol 22 2010 773 781